 |
On the Frontlines of Multiple SclerosisAuthor: ReachMD
Welcome to On the Frontlines of Multiple Sclerosis, a ReachMD series with the latest education and information on diagnostic and prognostic advancements and treatment options for patients with Multiple Sclerosis. Language: en Genres: Health & Fitness, Medicine, Science Contact email: Get it Feed URL: Get it iTunes ID: Get it |
Listen Now...
Disparities in DMT Access: Women with MS Are Less Likely to Receive Treatment
Sunday, 17 March, 2024
Host: Andrew Wilner, MD, FACP, FAAN Guest: Victoria Leavitt, PhD Disease-modifying therapies (DMTs) are an effective option for patients with multiple sclerosis (MS). In fact, a recent study presented at the 2023 joint ECTRIMS-ACTRIMS meeting in Italy found that MS patients being treated with a DMT had better cognitive function than those who were not. However, the same study also found that women are less likely than men to receive DMT treatment. Dive further into the findings with Dr. Andrew Wilner and Dr. Victoria Leavitt, Assistant Professor of Neuropsychology at Columbia University.
